SCHEMBL5776325

SCHEMBL5776325

CC(C)Cc1nc(Cl)c2nc(-c3ccccc3)cc-2[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 5/20 0.54
ADORA3 P0DMS8 4/20 0.54
ADORA2A P29274 4/20 0.54
ADORA2B P29275 2/20 0.54
GSK3B P49841 1/20 0.44
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 4/20 0.39
HPGD P15428 3/20 0.39
HSD17B10 Q99714 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
MAPT P10636 2/20 0.37
POLB P06746 1/20 0.37
PKM P14618 1/20 0.37
RAB9A P51151 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
XDH P47989 2/20 0.36
CDC7 O00311 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5773135 0.85 SMN1; SMN2 (0.55) ADORA1ADORA3ADORA2AADORA2BALDH1A1
SCHEMBL5769530 0.84 ADORA1 (0.54) ADORA1ADORA3ADORA2AADORA2BGSK3B
SCHEMBL5773513 0.83 ADORA3 (0.53) ADORA1ADORA3ADORA2AGSK3BALDH1A1
SCHEMBL5774041 0.80 ADORA3 (0.51) ADORA1ADORA3ADORA2AADORA2BGSK3B
SCHEMBL5774543 0.77 ADORA1 (0.48) ADORA1ADORA3ADORA2AALDH1A1KDM4E
SCHEMBL5771482 0.77 KDM4E (0.47) GSK3BALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5776767 0.77 KDM4E (0.47) ADORA1ADORA2AALDH1A1KDM4EHPGD
SCHEMBL5773970 0.72 ADORA1 (0.49) ADORA1ADORA3ADORA2AADORA2BALDH1A1
SCHEMBL5772105 0.71 KDM4E (0.44) ADORA1ADORA3ADORA2AALDH1A1KDM4E
SCHEMBL1501814 0.70 PDE10A (0.60) ADORA1ADORA3ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed